Dr. Suzanne Ildstad
As featured on
A Louisville company is making progress in clinical trials to help kidney transplant patients live without immunosuppressants.
The announcement follows Talaris Therapeutics’ unsuccessful effort to commercialize a stem cell therapy that promised to improve transplant recipients’ tolerance of new organs.
